Yahoo!
My Yahoo!
Mail
Sign In
[New User?
Sign Up
]
Finance Home
|
Help
Wednesday, February 10, 2010, 4:17pm SGT - The Singapore stock market closes in 43 minutes.
To create a watchlist or portfolio of shares,
Register
FINANCE HOME PAGE
INVESTING
FINANCE NEWS
Enter symbol(s):
Market:
Singapore
US
----------------
Argentina
Australia
Austria
Brazil
Canada - Toronto
Canada - Vancouver
China - Shanghai
China - Shenzhen
Denmark
France
Germany XETRA
Germany - Berlin
Hong Kong
India - Bombay
India - National
Indonesia
Israel
Italy
Korea
Korea - KOSDAQ
Malaysia
Mexico
Netherlands
New Zealand
Norway
Spain
Sweden
Switzerland
Taiwan OTC
Taiwan
Thailand
United Kingdom
Search by Company
|
Alphabetical List
Biogen Idec Inc. (BIIB)
At 5:00AM SGT:
54.09 USD
0.00 (0.00%)
MORE ON BIIB
Quotes
Summary
Options
Historical Prices
Charts
Basic Chart
Technical Chart
News & Info
Headlines
Company Events
Company
Profile
Key Statistics
SEC Filings
Competitors
Industry
Analyst Coverage
Analyst Opinion
Analyst Estimates
Research Reports
Star Analysts
Ownership
Insider Trans.
Insider Roster
Financials
Income Statement
Balance Sheet
Cash Flow
Biogen Idec Inc
(NasdaqNM:BIIB) Delayed quote data
Last Trade:
54.09 USD
Trade Time:
5:00AM SGT
Change:
0.00 (0.00%)
Prev Close:
54.09
Open:
N/A
Bid:
N/A
Ask:
N/A
1y Target Est:
52.60
Day's Range:
N/A - N/A
52wk Range:
41.75 - 55.37
Volume:
0
Avg Vol
(3m)
:
3,047,220
Market Cap:
15.64B
P/E
(ttm)
:
18.10
EPS
(ttm)
:
2.99
Div & Yield:
N/A (N/A%)
1d
5d
3m
6m
1y
2y
5y
max
Use Y! Toolbar to track stocks
Add BIIB to Portfolio
Download Data
HEADLINES
[$$] UAL Soars by 18%; Electronic Arts Falls
at The Wall Street Journal Online
(Wed 9:04am)
[$$] Earnings watch
at The Wall Street Journal Online
(Wed 8:35am)
Biogen Idec, Inc. Q4 2009 Earnings Call Transcript
at Seeking Alpha
(Wed 6:18am)
Biogen Beats & Guides Higher
Zacks.com
(Wed 5:18am)
Stocks Rally on Greece Hopes; Energy Surges
at CNBC
(Wed 2:24am)
Biogen reports higher profit, raises forecast
at MarketWatch
(Wed 2:10am)
Tuesday Options Update: BIIB, USO, MAC & NLY
at Seeking Alpha
(Wed 1:40am)
Biogen Idec surges on Tysabri sales
at bizjournals.com
(Wed 1:05am)
Biogen Idec Sales Rise on Tysabri Results
at Fox Business
(Wed 12:33am)
UPDATE - Biogen 4th-qtr profit up, outlook tops estimates
at Reuters
(Wed 12:32am)
Stocks Higher But Rating Cut Hits Banks
at CNBC
(Wed 12:29am)
Biogen Idec tops 4Q earnings expectations
at bizjournals.com
(Wed 12:05am)
More Headlines for BIIB...
ANALYST
EPS Est (next year)
(Dec-09)
:
3.98
EPS Est (in 2 years)
(Dec-10)
:
4.38
Avg Rec (current)*:
2.7
PEG Ratio:
1.53
* (Strong Buy) 1.0 - 5.0 (Strong Sell)
Analyst Opinion
-
Estimates
BUSINESS SUMMARY
Biogen Idec Inc., a biotechnology company, develops, manufactures, and commercializes novel therapeutics in the areas of oncology, neurology, immunology, and cardiology in the United States and internationally.
Full Company Profile
Add to Portfolio
Email to a Friend
Get
Summary
for Another Symbol:
Singapore
US
----------------
Argentina
Australia
Austria
Brazil
Canada - Toronto
Canada - Vancouver
China - Shanghai
China - Shenzhen
Denmark
France
Germany XETRA
Germany - Berlin
Hong Kong
India - Bombay
India - National
Indonesia
Israel
Italy
Korea
Korea - KOSDAQ
Malaysia
Mexico
Netherlands
New Zealand
Norway
Spain
Sweden
Switzerland
Taiwan OTC
Taiwan
Thailand
United Kingdom
Search by Company
Latest News
Singapore Indices